Poverty of ambition: To thrive, Indian pharma needs R&D investment, not just tariff cuts

Poverty of ambition: To thrive, Indian pharma requires R&D investment, not just tariff cuts. This is crucial for UPSC aspirants, especially for GS Paper 3, as it touches upon economic development and industry growth. Last Updated: 2025-03-12

Key Facts About Indian Pharmaceutical Industry

• India ranks 3rd in pharmaceutical production by volume.
• Market size for FY 2023-24 is USD 50 billion.
• Biotechnology sector valued at USD 137 billion in 2022.
• World’s largest supplier of generic medicines.
• Produces over 500 APIs, contributing 8% to global market.
• Medical devices market projected to grow to USD 50 billion by 2030.
• Indian drugs are cheaper than Western alternatives.
• Government support through Production-Linked Incentive scheme.
• Ranks 6th globally in patent applications.
• Exports medicines to over 200 nations.
• FY24 exports reached USD 27.82 billion.
• Challenges include quality issues and regulatory hurdles.
• Dependence on 70% API imports from China.
• Strict price controls hinder profitability.
• Emerging competition from Vietnam and Indonesia.
• Need for trained professionals in biotechnology.

India's Pharmaceutical Ambitions and Global Context

The Indian pharmaceutical industry is a cornerstone of the country's economic strategy, contributing significantly to global healthcare. With India ranking 3rd globally in production, the sector is pivotal for achieving economic growth targets. The market's projected growth to USD 130 billion by 2030 underscores its potential. However, to maintain its competitive edge, India must enhance its R&D capabilities, reducing reliance on API imports and overcoming regulatory challenges.

Related Government Schemes/Policies

• Production-Linked Incentive (PLI) Scheme: Encourages domestic manufacturing of pharmaceuticals and medical devices.

UPSC Relevance

• GS Paper 3: Economic Development - Industrial Growth and Infrastructure.
• Prelims: Questions on India's rank in global pharmaceutical production and export figures.
• Mains: Analytical themes on R&D investment in the pharmaceutical sector and its impact on economic growth.
• Essay Paper: Topics on innovation and industrial policy in India.

FAQ Section

• What is the significance of India's pharmaceutical industry?

  India ranks 3rd globally in pharmaceutical production, supplying over 50% of global vaccine demand, making it a critical player in global healthcare.

• Why is R&D investment important for Indian pharma?

  R&D investment is crucial to reduce dependency on imports, enhance drug quality, and maintain competitive pricing, supporting the projected market growth to USD 130 billion by 2030.

• What are the key features of the Indian pharmaceutical market?

  The market is characterized by its large volume production, significant export figures, and government support through schemes like the Production-Linked Incentive scheme.